Molecular Cytogenetics Industry Overview

The global molecular cytogenetics market size was estimated at USD 2.02 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.6% from 2023 to 2030.

The rising number of oncology cases, technological advancements in chromosome analysis tools, and the shift toward personalized medicine are the key factors boosting the market growth of molecular cytogenetics. Moreover, the increasing number of workshops and conferences for cytogenetic analysis is accelerating the molecular cytogenetic market. For instance, in April 2023, the University of Madras conducted a hands-on workshop on genomic techniques in clinical diagnostics, including cytogenetics.

Gather more insights about the market drivers, restrains and growth of the Molecular Cytogenetics Market

With the growing volume of genomic data, the integration of multi-omics data and the development of bioinformatics tools and algorithms are fueling the demand for molecular cytogenetics. These tools facilitate efficient data management, analysis, interpretation, and the discovery of meaningful associations between genetic alterations and disease phenotypes. Thus, the growing genomic pool is anticipated to propel the market for molecular cytogenetics during the forecast period.

Cancer is a primary cause of death across the world, accounting for approximately 10 million deaths in the year 2020. According to a WHO article published in February 2022, every year, nearly 400,000 kids develop cancer. Molecular cytogenetics provides techniques for cytology, epigenetics, and imaging in genetics, as well as the ability to detect chromosomal changes in cancer patients. Thus, the increasing prevalence of cancer is expected to offer lucrative opportunities for the market during the study period.

Furthermore, the growing prevalence of uncommon infections is also expected to propel the demand for the market. The growing knowledge and correlation of features of the human genomic pool have paved the way for various research & development activities for developing personalized medicines. In addition, operating players in the market are introducing novel molecular cytogenetics tools for improved patient care and outcomes. For instance, in October 2021, Phase Genomics, Inc. launched a next-generation cytogenomics platform to advance precision diagnosis and treatment in oncology and reproductive genetics, thereby boosting market growth.

Browse through Grand View Research's Biotechnology Industry Research Reports.

  • The global epigenetics market size was estimated at USD 14.63 billion in 2023 and is projected to grow at a CAGR of 15.3% from 2024 to 2030.
  • The global bioinformatics market size was valued at USD 10.1 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 13.7% from 2023 to 2030.

Molecular Cytogenetics Market Segmentation

Grand View Research has segmented the global molecular cytogenetics market based on application, technology, product, end-use, and region:

Molecular Cytogenetics Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Genetic Disorders
  • Oncology
  • Personalized Medicine
  • Other Applications

Molecular Cytogenetics Technology Outlook (Revenue, USD Million, 2018 - 2030)

  • Comparative Genomic Hybridization
  • FISH
  • Immunohistochemistry
  • Karyotyping
  • thers

Molecular Cytogenetics Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Instruments
  • Consumables
  • Software & Services

Molecular Cytogenetics End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Clinical & Research Laboratories
  • Hospitals & Path Labs
  • Academic Research Institutes
  • Pharmaceutical & Biotech Companies
  • Others

Molecular Cytogenetics Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Key Companies profiled:

  • Danaher
  • MetaSystems
  • BIOVIEW
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abbott,
  • Illumina, Inc.
  • Hoffmann-La Roche Ltd.
  • Oxford Gene Technology
  • PerkinElmer Inc.

Key Molecular Cytogenetics Company Insights

Companies are focusing on expansions, the development of innovative medical devices, and technological advances. Moreover, partnerships, mergers, and acquisitions for novel product development constitute some of the strategic initiatives implemented by major players. For instance, in June 2023, Oxford Gene Technology (OTG) entered into a partnership with Applied Spectral Imaging (ASI) to strengthen OTG’s cytogenetic imaging and analysis solutions in Great Britain. The initiative is predicted to offer enhancements in workflow automation and overall efficacy to enable quicker diagnostic decision-making.

Order a free sample PDF of the Molecular Cytogenetics Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.